Home › Type 1 Diabetes › Pennsylvania
Type 1 Diabetes clinical trials in Pennsylvania
13 studies for Type 1 Diabetes are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Children's Hospital of Philadelphia (CHOP), Philadelphia
RecruitingPhase 3
Ages 1 to 35 · All sexes · Updated Sep 22, 2026 · NCT07222332A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Children's Hospital of Philadelphia (CHOP), Philadelphia
RecruitingPhase 3
Ages 1 to 35 · All sexes · Updated Sep 22, 2026 · NCT07222137A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- The Children's Hospital of Philadelphia- Site Number : 8400039, Philadelphia
RecruitingPhase 3
Ages 1 to 25 · All sexes · Updated Sep 14, 2026 · NCT07088068Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- University of Pittsburgh, Pittsburgh
RecruitingPhase 2
Ages 4 to 34 · All sexes · Updated Sep 9, 2026 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- University of Pittsburgh, Pittsburgh
RecruitingPhase 2
Ages 8 to 45 · All sexes · Updated Sep 8, 2026 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- University of Pittsburgh, Pittsburgh
RecruitingPhase 1/2
Ages 9 to 20 · All sexes · Updated Sep 2, 2026 · NCT07061574A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Hospital of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center Montefiore, Pittsburgh
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT04786262SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- The Children's Hospital of Philadelphia, Philadelphia
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
RecruitingPhase 2
Ages 5 to 40 · All sexes · Updated Aug 24, 2026 · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Pennsylvania, Philadelphia
Recruiting
Ages 18 to 65 · All sexes · Updated Jul 16, 2026 · NCT06880835Registry for Stage 2 Type 1 Diabetes
- Hospital of The University of Pennsylvania- Site Number : 8400021, Philadelphia
- The Children's Hospital of Philadelphia- Site Number : 8400029, Philadelphia
RecruitingObservational study
All ages · All sexes · Updated Apr 13, 2026 · NCT06481904An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
- Perelman Center for Advanced Medicine - Endocrinology, Philadelphia
- Montefiore Clinical and Translational Research Center - Endocrinology, Pittsburgh
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Mar 23, 2026 · NCT06832410Closed Loop and Education for Hypoglycemia Awareness Restoration
- University of Pennsylvania, Philadelphia
Recruiting
Ages 18 to 75 · All sexes · Updated Mar 3, 2026 · NCT06325202TrialNet Pathway to Prevention of T1D
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 45 · All sexes · Updated Jul 1, 2025 · NCT00097292From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.